Curis Lifesciences IPO will hit the market on November 07, 2025, and closes on November 11, 2025. The Curis Lifesciences IPO GMP Kostak rate and subject to Sauda updated as of today. The Curis Lifesciences IPO Grey Market Premium has started with low premium rates at this time, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check Curis Lifesciences IPO subscription status here.
Curis Lifesciences specializes in the development, manufacturing, and distribution of pharmaceutical formulations, including tablets, capsules, oral liquids, and sterile and non-sterile ointments. Their portfolio spans various therapeutic segments, with a reputation for quality-driven manufacturing and a focus on innovation and compliance with international regulatory standards.
The company operates a state-of-the-art manufacturing facility in Sanand, Ahmedabad, equipped with advanced technology and quality control systems to ensure the highest standards of safety and efficacy in its products.
Curis Lifesciences IPO Issue size of ₹27.52 Crores, in which Fresh Issue of ₹27.52 Crores and issue price band has been fixed at ₹120 to ₹128 Per Share. The Curis Lifesciences IPO will be listed on November 14, 2025, NSE SME.
What is Curis Lifesciences IPO GMP Today?
- The Curis Lifesciences IPO GMP Today Or Grey Market Premium is ₹0.
What is Curis Lifesciences IPO Kostak Rates Today?
- The Curis Lifesciences IPO Kostak rate is ₹0.
What is Curis Lifesciences IPO Subject to Sauda Price Today?
- The Curis Lifesciences IPO Subject to Sauda rates is ₹0.
Curis Lifesciences IPO Approximately Returns?
- The Curis Lifesciences IPO’s approximate return is -%, which can also change according to the Market Sentiment.
Curis Lifesciences IPO GMP Today Live :
| Date | GMP | Kostak | Subject |
| 04 Nov 2025 | ₹0  | ₹0 | ₹0 |
| 03 Nov 2025 | ₹0 | ₹0 | ₹0 |
| 02 Nov 2025 | ₹0 | ₹0 | ₹0 |
| 01 Nov 2025 | ₹0 | ₹0 | ₹0 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your research before investing in an IPO, regardless of the GMP.
- The IPO GMP is estimated, considering market volatility, limited historical data, underwriting conditions, legal risks, and potential dilution.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price: The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on a number of factors, including the overall market sentiment and the performance of the company in the post-IPO period.
- The GMP can be volatile: The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even Octline in value after listing.
- Investing in IPOs carries risks: IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
- Risk Factors: Identify and articulate the key risk factors that could impact the IPO GMP and subsequent trading of the company’s shares. These may include industry-specific risks, regulatory uncertainties, economic downturns, and competitive pressures.
- Warning: IPO GMP data is purely indicative and should not be considered as a reliable basis for investment decisions. It does not guarantee actual listing performance or returns.
Disclaimer: Stock Market Investments are Subject to Market risks, read all scheme Related Document Carefully Before Investing.